-
KeyBanc Bullish On Cooper Companies' Revenue Momentum, But Says Mix May Hurt Margins
Friday, October 11, 2019 - 12:44pm | 324Read More...While Cooper Companies Inc (NYSE: COO) should be able to sustain its revenue growth momentum, despite changes in the competitive landscape, its gross margin may come under pressure due to mix shift and capacity investments, according to KeyBanc Capital Markets. The Analyst KeyBanc’s Matthew...
-
Baxter Investors 'Know What They're Getting,' KeyBanc Says
Wednesday, June 26, 2019 - 3:41pm | 316Read More...Hospital and surgical product maker Baxter International Inc (NYSE: BAX) is the kind of company that wins a bunch of "singles and doubles" but has no clear catalyst to drive material upside, according to KeyBanc Capital Markets. The Analyst KeyBanc's Matthew Mishan initiated coverage...
-
KeyBanc: 3 Reasons Why Invacare Is No Longer A Buy
Thursday, August 16, 2018 - 10:04am | 388Read More...Invacare Corporation (NYSE: IVC), a manufacturer and distributor of medical equipment used in non-acute care settings, signaled in its second-quarter earnings report a turnaround is not progressing as rapidly as expected, according to KeyBanc Capital Markets. The Analyst KeyBanc Capital...
-
3 Reasons Why Cooper Companies Landed A KeyBanc Upgrade
Monday, July 30, 2018 - 9:31am | 406Read More...A bullish case for medical device manufacturer Cooper Companies Inc (NYSE: COO) can now be made for three reasons, according to KeyBanc Capital Markets. The Analyst KeyBanc's Matthew Mishan upgraded Cooper Companies from Sector Weight to Overweight with a new $298 price target....
-
Halyard Health Has 34% Upside Potential, KeyBanc Says In Upgrade
Friday, April 6, 2018 - 9:54am | 378Read More...Following investor meetings with Halyard Health Inc (NYSE: HYH) CEO Joe Woody, KeyBanc Capital Markets came away with a bullish stance on the medical technology company. The Analyst Analyst Matthew Mishan upgraded shares of Halyard Health from Sector Weight from Overweight with a $61...
-
KeyBanc Initiates Becton, Dickinson And Co. With Bullish Stance
Friday, January 5, 2018 - 11:16am | 374Read More...Becton Dickinson and Co (NYSE: BDX) was initiated with a top-notch rating by KeyBanc Capital Markets Thursday. The Analyst KeyBanc analyst Matthew Mishan initiated coverage on Becton Dickinson with an Overweight and $260 price target. The Thesis "We believe [the company] is...
-
KeyBanc Downgrades Steris, Sees 'Binomial Outcome' Pending Litigation
Thursday, June 4, 2015 - 9:16am | 321Read More...In a report published Thursday, KeyBanc Capital analyst Matthew Mishan downgraded the rating on STERIS Corp (NYSE: STE) from Overweight to Sector Weight. The analyst believes that the company is unlikely to be able to mitigate FTC concerns, and a preliminary injunction hearing is likely to be...
-
ArvinMeritor, Inc. (ARM) Maintains Buy Rating
Tuesday, March 23, 2010 - 11:08am | 124Read More...Analysts Brett D. Hoselton and Matthew Mishan at KeyBanc Capital Markets have released an update on ArvinMeritor, Inc. (NYSE: ARM). KeyBanc Capital Markets recently hosted a small group teleconference with the management at ArvinMeritor. Following the conference, it has maintained its Buy rating...
